Related Experiment Video
Updated: May 25, 2026

09:26
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
Aqp 9 and brain tumour stem cells.
Guri Fossdal1, Einar O Vik-Mo, Cecilie Sandberg
1Vilhelm Magnus laboratory, Institute for Surgical Research, Norwegian National Hospital, Oslo University Hospital, 0450 Oslo, Norway.
Thescientificworldjournal
|January 21, 2012
Summary
Aquaporins (AQP) 1, 4, and 9 are linked to malignant brain tumors. AQP9 shows high expression in glioblastoma progenitor cells, suggesting a key role in tumor development.
Area of Science:
- Neuroscience
- Molecular Biology
- Oncology
Background:
- Aquaporins (AQP) 1, 4, and 9 are implicated in malignant brain tumor pathogenesis.
- These aquaporins may influence tumor cell motility, invasiveness, edema, and metabolism under hypoxia.
Purpose of the Study:
- To investigate the expression of AQP1, AQP4, and AQP9 in glioblastoma.
- To analyze AQP expression in tumor stem cells, progenitor cells, and differentiated cells compared to normal brain counterparts.
Main Methods:
- Quantitative Polymerase Chain Reaction (qPCR) on glioblastoma biopsies and cell cultures.
- Immunostaining of tumor progenitor and differentiated cells.
- Comparison with normal rat brain stem and differentiated cells.
Main Results:
- qPCR confirmed the presence of AQP1, AQP4, and AQP9 in tumor tissue.
- AQP9 was highly expressed in tumor progenitor cells, while AQP4 was downregulated in differentiated tumor cells.
- Immunostaining showed high AQP9 expression in differentiated cultures, not progenitor cells, contradicting mRNA findings.
Conclusions:
- Aquaporin 9 (AQP9) expression patterns differ between progenitor and differentiated glioblastoma cells.
- AQP9's role in glioblastoma tumorigenesis is complex, with potential involvement in differentiated tumor cells.
- Further investigation into AQP9's specific functions in glioblastoma development is warranted.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

